logo
  

Xerox Holdings Confirms Steven Bandrowczak As CEO

Xerox Holdings Corp. (XRX) announced Wednesday that its Board of Directors has appointed Steven Bandrowczak as Chief Executive Officer.

Bandrowczak joined Xerox in 2018 as the company's President and Chief Operations Officer, and has served as Interim CEO since the passing of John Visentin in June 2022. He was also president of Xerox Holdings Corp. and served as CareAR's Chairman.

Bandrowczak joined Xerox in 2018 from Alight Solutions, where he was the chief operating officer and chief information officer. Prior to Alight Solutions, he was the president of Telecommunication Media and Technology at Sutherland Global Services.

He previously served as the senior vice president for Global Business Services at Hewlett-Packard. In addition, Steve led the business process outsourcing (BPO) practice in the Enterprise Services Group.

During his career, Steve has held senior leadership positions for various multi-billion-dollar global companies, including Avaya, Nortel, Lenovo, DHL and Avnet.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT